BIO Investor Forum 2005 to Webcast OrthoLogic Presentation
October 12 2005 - 5:30PM
PR Newswire (US)
TEMPE, Ariz., Oct. 12 /PRNewswire-FirstCall/ -- OrthoLogic Corp.
(NASDAQ:OLGC) announced today that management will provide an
overview of the Company and an update on its lead compound for
tissue and bone healing, Chrysalin(R), at the BIO Investor Forum
2005. The presentation will be delivered at 1:40 p.m. PDT (4:40
p.m. EDT) on Thursday, October 20, 2005 from The Palace Hotel in
San Francisco. The presentation will be webcast live and may be
accessed by visiting the Investors section of the Company's
website, http://www.orthologic.com/. It will be archived for 30
days. OrthoLogic is a biotechnology company focused on the
development and commercialization of the novel synthetic peptide
Chrysalin(R) (TP508) in three lead indications, all of which
represent areas of significant unmet medical need -- fracture
repair, diabetic foot ulcer healing and cartilage defect repair.
Based on the Company's pioneering scientific research of the
natural healing cascade, OrthoLogic has become the leading company
focused on tissue and bone repair. OrthoLogic is committed to
developing a pipeline of novel peptides and other molecules aimed
at helping patients with equally under-served conditions. The
Company maintains exclusive worldwide rights for Chrysalin.
OrthoLogic's corporate headquarters are in Tempe, Arizona. For more
information, please visit the company's Web site:
http://www.orthologic.com/. DATASOURCE: OrthoLogic Corp. CONTACT:
Media, Lauren Tortorete of Biosector 2, +1-212-845-5609; or
Investors, Melanie Friedman of Stern Investor Relations,
+1-212-362-1200, both for OrthoLogic Corp. Web site:
http://www.orthologic.com/
Copyright
Orthologic (MM) (NASDAQ:OLGC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Orthologic (MM) (NASDAQ:OLGC)
Historical Stock Chart
From Jul 2023 to Jul 2024